Your browser doesn't support javascript.
loading
Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial.
Schwartz, Gregory G; Szarek, Michael; Bhatt, Deepak L; Bittner, Vera A; Bujas-Bobanovic, Maja; Diaz, Rafael; Fazio, Sergio; Fras, Zlatko; Goodman, Shaun G; Harrington, Robert A; Jukema, J Wouter; Manvelian, Garen; Pordy, Robert; Ray, Kausik K; Scemama, Michel; White, Harvey D; Steg, Ph Gabriel.
Afiliação
  • Schwartz GG; Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Szarek M; CPC Clinical Research, Aurora, CO, USA.
  • Bhatt DL; State University of New York, Downstate Health Sciences University, Brooklyn, NY, USA.
  • Bittner VA; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, New York, NY, USA.
  • Bujas-Bobanovic M; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Diaz R; Sanofi Research and Development, Paris, France.
  • Fazio S; Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina.
  • Fras Z; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
  • Goodman SG; Preventive Cardiology Unit, Department of Vascular Medicine, Division of Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Harrington RA; University Medical Centre Ljubljana, Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Jukema JW; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
  • Manvelian G; St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Pordy R; Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Ray KK; Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Scemama M; Netherlands Heart Institute, Utrecht, the Netherlands.
  • White HD; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
  • Steg PG; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
Eur Heart J ; 2023 Mar 05.
Article em En | MEDLINE | ID: mdl-36879424
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: Eur Heart J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: Eur Heart J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos